Spironolactone



Spironolactone





(speer on oh lak’ tone)

Aldactone, Novo-Spiroton (CAN)

PREGNANCY CATEGORY C

PREGNANCY CATEGORY D (GESTATIONAL HYPERTENSION)


Drug Classes

Aldosterone antagonist

Potassium-sparing diuretic


Therapeutic Actions

Competitively blocks the effects of aldosterone in the renal tubule, causing loss of sodium and water and retention of potassium.


Indications



  • Diagnosis and maintenance of primary hyperaldosteronism


  • Adjunctive therapy in edema associated with HF, nephrotic syndrome, hepatic cirrhosis when other therapies are inadequate or inappropriate


  • Treatment of hypokalemia or prevention of hypokalemia in patients who would be at high risk if hypokalemia occurred (eg, patients receiving cardiac glycosides), patients with cardiac arrhythmias


  • Essential hypertension, usually in combination with other drugs


  • Adjunctive therapy for treatment of severe heart failure (NYHA class III to IV) to increase survival and decrease need for hospitalization


  • Unlabeled uses: Treatment of hirsutism because of its antiandrogenic properties, palliation of symptoms of PMS, treatment of familial male precocious puberty, short-term treatment of acne vulgaris, pediatric hypertension



Available Forms

Tablets—25, 50, 100 mg


Dosages

Adults

Jul 21, 2016 | Posted by in NURSING | Comments Off on Spironolactone

Full access? Get Clinical Tree

Get Clinical Tree app for offline access